<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-30004" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Tetralogy of Fallot</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Horenstein</surname>
            <given-names>Maria S.</given-names>
          </name>
          <aff>CHOC (Children's Hospital of Orange County)</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Guillaume</surname>
            <given-names>Melissa</given-names>
          </name>
          <aff>The Brooklyn Hospital Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Maria Horenstein declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Melissa Guillaume declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>14</day>
          <month>2</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-30004.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Tetralogy of Fallot (TOF) is the most common cyanotic congenital heart disease, representing 5% to 7% of all congenital heart defects. TOF is a conotruncal cardiac defect characterized by a large and anteriorly malaligned ventricular septal defect, an overriding aortic root, and narrowing of the subpulmonary and pulmonary valves. Right ventricular hypertrophy is secondary to the obstruction in the right ventricular outflow tract and pulmonary valve.&#x000a0;Clinical presentation varies based on the severity of the right ventricular outflow tract obstruction (RVOTO), most commonly presenting as a cyanotic neonate. With the advent of fetal echocardiography, the diagnosis can be made prenatally, and in infants who present with severe RVOTO, prompt stabilization can avoid profound cyanosis and rapid deterioration. This activity for healthcare professionals aims to enhance learners' competence in selecting appropriate diagnostic tests, managing TOF, and fostering effective interprofessional teamwork to improve outcomes.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify&#x000a0;the anatomy and interpret the pathophysiology of TOF.</p></list-item><list-item><p>Identify&#x000a0;the known genetic risk factors associated with TOF.</p></list-item><list-item><p>Select the appropriate treatment for patients with TOF.</p></list-item><list-item><p>Coordinate with interprofessional healthcare team members caring for&#x000a0;patients with TOF, including maternal-fetal care, neonatal cardiac surgery, cardiac neurodevelopmental programs, outpatient care programs, and adult congenital programs.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30004&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30004">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-30004.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Classic tetralogy of Fallot (TOF) is a congenital&#x000a0;heart defect (CHD) that is comprised of 4 anatomical alterations: a large, anteriorly malaligned ventricular septal defect (VSD), an overriding aorta which results in infundibular (ie, sub-pulmonary) right ventricular outflow tract obstruction (RVOTO), and consequent right ventricular hypertrophy secondary to chronic systemic pressures. The pulmonary valve annulus is often hypoplastic, with a pulmonary valve that is dysplastic and stenotic. The VSD is most frequently located in the perimembranous septum; however, the defect can extend to the muscular septum, and infrequently, there might be additional muscular VSDs.<xref ref-type="bibr" rid="article-30004.r1">[1]</xref>&#x000a0;A right aortic arch is observed in 20% to 25% of TOF.<xref ref-type="bibr" rid="article-30004.r2">[2]</xref></p>
        <p>The clinical presentation will also depend on the associated cardiovascular anomalies in roughly 40% of patients with TOF. These may&#x000a0;include atrial septal defects, patent ductus arteriosus, supravalvar pulmonary stenosis, branch pulmonary artery stenoses, hypoplastic branch pulmonary arteries, pulmonary valve atresia which may&#x000a0;develop during fetal life as the subpulmonary infundibular narrowing progresses, a disconnected left pulmonary artery that originates from the ascending aorta formerly known as <italic toggle="yes">hemitruncus</italic>, a left pulmonary artery arising from the ductus arteriosus, absent left pulmonary artery, absent pulmonary valve, anomalous coronary arteries, anomalous pulmonary venous return, aortic incompetence, aortopulmonary window, and atrioventricular septal defect (AVSD).<xref ref-type="bibr" rid="article-30004.r3">[3]</xref>&#x000a0;</p>
        <p>Patients&#x000a0;with TOF and pulmonary atresia may have a remnant of a pulmonary artery trunk with&#x000a0;different calibers of the central pulmonary arteries and variable pulmonary tree anatomy. In approximately 50% of these patients, the right and left pulmonary arteries are confluent, and blood flow is ductal-dependent. In the other 50%, pulmonary flow is from multiple collateral vessels, usually from the descending thoracic aorta, and is not ductal-dependent. Occasionally, collateral arteries might arise from the head and neck, abdominal aorta, or coronary arteries. Surgical repair requires unifocalization of the many aortopulmonary collaterals, which can be quite challenging.<xref ref-type="bibr" rid="article-30004.r2">[2]</xref></p>
        <p>TOF associated with rudimentary pulmonary valve leaflets, which occurs in 3% to 6% of cases, is known as &#x0201c;TOF with absent pulmonary valve.&#x0201d; In these patients, the main and branch pulmonary arteries are aneurysmal. Some degree of RVOTO is due to the presence of a small pulmonary annulus. The ductus arteriosus is usually absent, and approximately 50% have a right-sided aortic arch. Occasionally, one of the branch pulmonary arteries may arise from the aorta or may be absent.<xref ref-type="bibr" rid="article-30004.r2">[2]</xref>&#x000a0;Approximately 2% of patients with TOF have an associated atrioventricular septal defect (AVSD). Because the RVOTO limits pulmonary overcirculation, these patients usually do not display symptoms of congestive heart failure. Therefore, primary surgical repair can be performed within the first few months of life.<xref ref-type="bibr" rid="article-30004.r2">[2]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-30004.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>TOF is the most frequently occurring conotruncal or outflow tract malformation, sharing this classification with other CHD (eg, truncus arteriosus, interrupted aortic arch, transposition of the great arteries, and double outlet right ventricle). In conotruncal malformations, suppression of developmental networks such as the NOTCH and WNT pathways during early embryogenesis produces malfunction of downstream regulatory pathways that lead to faulty structural cardiac development.<xref ref-type="bibr" rid="article-30004.r4">[4]</xref>&#x000a0;</p>
        <p>Approximately 75% to 80% of TOF cases are nonsyndromic, meaning that the patient has an isolated cardiac defect. Of these, 7% have a loss of function gene mutation, including <italic toggle="yes">NOTCH1</italic>, <italic toggle="yes">FLT4</italic>, and <italic toggle="yes">TBX1,</italic>&#x000a0;a transcription factor involved in cardiac development that is affected in those with 22q11.2 microdeletion.<xref ref-type="bibr" rid="article-30004.r5">[5]</xref>&#x000a0;Mutations in certain transcription factors involved in cardiac morphogenesis (eg, <italic toggle="yes">NKX2.5, GATA-6, GATA-4, HAND1, HAND2, ZFPM2</italic>, and <italic toggle="yes">NF-ATC</italic>) have also been associated with nonsyndromic TOF.<xref ref-type="bibr" rid="article-30004.r6">[6]</xref><xref ref-type="bibr" rid="article-30004.r7">[7]</xref>&#x000a0;In general, mutations in the <italic toggle="yes">NKX2.5</italic> gene are commonly observed in familial CHD. Not surprisingly, CHDs reoccur in approximately 3% of affected families, though not necessarily TOF, when compared to the general population.<xref ref-type="bibr" rid="article-30004.r8">[8]</xref></p>
        <p>The remaining&#x000a0;20% to 25% of patients with TOF have an associated syndrome or a chromosomal abnormality, with the most frequent being trisomy 21 (ie, Down syndrome) and the 22q11.2 deletion syndromes, which range from the more severe DiGeorge syndrome that is accompanied by dysmorphic facies, palatal abnormalities, immune deficiencies, hypocalcemia, and learning disabilities, to the less severe Sprintzen or velocardiofacial syndrome which does not have the immune deficiency and hypocalcemia. Because 22% to 48% of patients&#x000a0;with a&#x000a0;22q11.2 microdeletion&#x000a0;have an interrupted aortic arch, and 24% have a right-sided aortic arch,&#x000a0;TOF is not infrequently associated with aortic arch malformations. When a patient with TOF&#x000a0;presents with pulmonary valve atresia, the association with 22q11.2 microdeletion increases to 40%. Thus, genetic testing is currently recommended in fetuses with TOF to assess for the 22q11.2 microdeletion, especially since outcomes are worse than in those who do not carry the microdeletion.<xref ref-type="bibr" rid="article-30004.r8">[8]</xref></p>
        <p>TOF can also occur in patients with known genetic mutations, including <italic toggle="yes">JAG1</italic> and <italic toggle="yes">NOTCH2</italic> genes (ie, Alagille syndrome), <italic toggle="yes">KMT2D</italic> and <italic toggle="yes">KDM6A</italic> genes (ie, Kabuki syndrome), <italic toggle="yes">CHD7</italic> gene (ie, CHARGE syndrome), and the <italic toggle="yes">PTPN11, SOS1</italic> or <italic toggle="yes">RAF1</italic> genes (ie, Noonan syndrome). TOF may also be present in patients with unknown mutations (eg, VACTERL association and Goldenhar syndrome).<xref ref-type="bibr" rid="article-30004.r9">[9]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-30004.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>CHD is&#x000a0;found&#x000a0;in approximately 1% to 1.2% of live births.<xref ref-type="bibr" rid="article-30004.r10">[10]</xref>&#x000a0;TOF is the most common cyanotic CHD, with a nearly equal sex distribution, a prevalence of 1 out of 3,000 births,&#x000a0;and an incidence of 5 to 7 out of 10,000 live births. TOF represents 5% to 7% of all CHD.<xref ref-type="bibr" rid="article-30004.r4">[4]</xref><xref ref-type="bibr" rid="article-30004.r1">[1]</xref><xref ref-type="bibr" rid="article-30004.r6">[6]</xref><xref ref-type="bibr" rid="article-30004.r4">[4]</xref>&#x000a0;Medical and surgical advances have allowed an increased prevalence of CHD among older children and adults, with a current estimated adult&#x000a0;CHD patient US population of approximately 1 million, of which an estimated 15% are TOF patients.<xref ref-type="bibr" rid="article-30004.r11">[11]</xref>&#x000a0;In contrast, without surgical intervention, survival decreases as the patient ages. Patients with unrepaired TOF have&#x000a0;an estimated survival rate of 66%&#x000a0;at 1 year of age, 40%&#x000a0;at&#x000a0;3 years, 11% at&#x000a0;20 years, 6%&#x000a0;at&#x000a0;30 years, and 3% at 40 years.<xref ref-type="bibr" rid="article-30004.r12">[12]</xref></p>
      </sec>
      <sec id="article-30004.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The&#x000a0;VSD in TOF is typically large or nonrestrictive,&#x000a0;allowing pressure equalization within&#x000a0;the&#x000a0;ventricles. Therefore, whether the shunting is left to right or vice versa will depend on the degree of downstream pressure the blood flow encounters. With significant RVOTO, most of the blood will&#x000a0;shunt toward the aorta, thereby bypassing the pulmonary bed&#x000a0;with consequent cyanosis. Conversely, if the resistance across the RVOT is less than the systemic vascular resistance, most of the blood will be directed to the pulmonary vascular bed, and the patient&#x000a0;will be minimally cyanotic or acyanotic&#x000a0;(see&#x000a0;<bold>Image.</bold>&#x000a0;Tetralogy of Fallot).<xref ref-type="bibr" rid="article-30004.r13">[13]</xref>&#x000a0;</p>
        <p>Different factors can contribute to RVOTO, including&#x000a0;a stenotic pulmonary valve, a hypoplastic pulmonary valve annulus, the deviation of the infundibular septum that causes subvalvular obstruction, and the hypertrophy of the muscular bands of the RVOT. The obstruction across the RVOT can also be dynamic with sudden increases in cyanosis, a phenomenon known as &#x0201c;Tet or hypoxic spells.&#x0201d; The physiological process surrounding these hypercyanotic episodes is yet to be fully understood but appears to involve a decrease in systemic vascular resistance or an increase in pulmonary vascular resistance. The result is an increase in the right-to-left shunting across the ventricular septal defect,&#x000a0;which produces marked desaturation. These episodes can be triggered by agitation, pain, anemia, fever, hypovolemia,&#x000a0;or peripheral vasodilatation.&#x000a0;These hypoxic spells occur in infants or children but do not occur in adults.<xref ref-type="bibr" rid="article-30004.r14">[14]</xref><xref ref-type="bibr" rid="article-30004.r13">[13]</xref></p>
        <p>Patients with TOF and pulmonary atresia are usually cyanotic in the newborn period, with worsening cyanosis as the ductus arteriosus closes. This becomes a lethal condition in the absence of sufficient&#x000a0;blood flow&#x000a0;from aortopulmonary collaterals. Patients with an absent pulmonary valve do not typically have cyanosis. However, these patients have aneurysmal branch pulmonary arteries&#x000a0;that usually cause external compression of the airways, leading to tracheobronchomalacia with air trapping.<xref ref-type="bibr" rid="article-30004.r2">[2]</xref>&#x000a0;Approximately 10% to 35% of adult patients with TOF may have atrial arrhythmias (eg, reentrant atrial tachycardia and atrial fibrillation).<xref ref-type="bibr" rid="article-30004.r11">[11]</xref>&#x000a0;Ventricular arrhythmias can occur in up to 10% of patients, and sudden death&#x000a0;is estimated to occur in 0.2% of patients each year of follow-up.<xref ref-type="bibr" rid="article-30004.r8">[8]</xref>&#x000a0;Life-threatening arrhythmias&#x000a0;occur&#x000a0;more frequently in&#x000a0;those with moderate to severe pulmonary valve insufficiency with RV dilatation and fibrosis and in those with biventricular dysfunction with congestive heart failure.&#x000a0;Therefore, life-long monitoring is recommended.<xref ref-type="bibr" rid="article-30004.r15">[15]</xref>&#x000a0;Progressive aortic root dilatation in repaired TOF with progressive aortic valve regurgitation is less common but&#x000a0;warrants follow-up, as this may require aortic root replacement.<xref ref-type="bibr" rid="article-30004.r16">[16]</xref></p>
      </sec>
      <sec id="article-30004.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>
<bold>Clinical Symptoms</bold>
</p>
        <p>Clinical presentation varies based on the severity of the RVOTO, most commonly presenting as a cyanotic neonate. Adult patients with TOF may have dyspnea and exercise intolerance. With the advent of fetal echocardiography, the diagnosis can be made prenatally, and in infants who present with severe RVOTO, prompt stabilization can avoid profound cyanosis and rapid deterioration.<xref ref-type="bibr" rid="article-30004.r17">[17]</xref>&#x000a0;</p>
        <p>In those undiagnosed before birth, presentation depends on the degree of obstruction to the RV outflow. Those with moderate&#x000a0;RVOTO&#x000a0;may be asymptomatic at presentation, except for the presence of a loud murmur, and may be referred to as "pink Tets." Those with minimal RVOTO behave as those&#x000a0;who have a large VSD and will present with symptoms of pulmonary overcirculation as&#x000a0;the pulmonary vascular resistance falls after a few weeks of life.&#x000a0;Because RVOTO&#x000a0;usually increases with time, pink Tets can later&#x000a0;develop cyanosis and hypercyanotic spells when crying or&#x000a0;in hypovolemia.<xref ref-type="bibr" rid="article-30004.r17">[17]</xref>&#x000a0;Patients with TOF and absent pulmonary valves can present primarily with&#x000a0;respiratory distress from tracheobronchial compression from&#x000a0;the dilated pulmonary arteries; cyanosis in these patients is usually mild.<xref ref-type="bibr" rid="article-30004.r18">[18]</xref>&#x000a0;</p>
        <p>"Tet spells" or hypercyanotic episodes can occur in infants or toddlers with unrepaired TOF, characterized by tachypnea and hyperpnea and a decrease in the intensity of the cardiac murmur. Some patients will be inconsolable in addition to worsening cyanosis. These episodes can either subside spontaneously or can cause syncope with or without cardiac arrest. Thus, rapid intervention should be provided with a referral for prompt primary repair or palliation. If the patient survives&#x000a0;such episodes&#x000a0;but remains unrepaired, "Tet spells" tend to become rare and may disappear by&#x000a0;4 to 5 years of age. Presently, patients with TOF presenting with cyanosis and severe, longstanding cyanosis are rare in developed countries with adequate pediatric cardiac services.<xref ref-type="bibr" rid="article-30004.r19">[19]</xref><xref ref-type="bibr" rid="article-30004.r20">[20]</xref></p>
        <p>The clinical manifestations of patients with TOF and absent pulmonary valves depend on the severity of respiratory distress, ranging from those with no respiratory distress to those with severe respiratory distress due to&#x000a0;trachea and main stem bronchi compression by the massive pulmonary artery branches.<xref ref-type="bibr" rid="article-30004.r21">[21]</xref>&#x000a0;The degree of obstructive airway disease among these patients varies markedly. Some patients will improve with prone positioning. Otherwise, intubation and positive pressure ventilation are required.<xref ref-type="bibr" rid="article-30004.r18">[18]</xref>&#x000a0;Patients with TOF and absent pulmonary valves&#x000a0;usually have to-and-fro systolic and diastolic murmurs and a single-second heart sound. As newborns, these patients are typically cyanotic; however, the cyanosis improves by&#x000a0;the first week of life. Due to a lesser degree of RVOTO, as pulmonary vascular resistance naturally decreases during the first days of life, these patients may exhibit signs and symptoms of pulmonary overcirculation with tachypnea, excessive diaphoresis with feeds, and failure to thrive.<xref ref-type="bibr" rid="article-30004.r22">[22]</xref></p>
        <p>
<bold>Physical Exam Findings</bold>
</p>
        <p>Patients with TOF may&#x000a0;have a typical first heart sound with a single-second heart sound because the pulmonic component is usually inaudible. The greater the degree of obstruction, the more prominent the murmur, usually described as crescendo-decrescendo with a harsh systolic ejection quality&#x000a0;and best heard at the left mid to upper sternal border with posterior radiation. Sometimes, the murmur can have a regurgitant quality, and an early systolic click may be auscultated along the left sternal border attributed to the flow&#x000a0;through a&#x000a0;dilated ascending aorta. A prominent ventricular impulse and a systolic thrill may be palpable. A continuous&#x000a0;murmur can be heard over the back and axillary regions in patients with pulmonary atresia and aortopulmonary collaterals.<xref ref-type="bibr" rid="article-30004.r13">[13]</xref></p>
        <p>Adult patients with TOF may have findings that include severe or free pulmonary insufficiency with RV dilatation, severe tricuspid valve regurgitation, and RV dyssynchrony from right bundle branch block (RBBB)&#x000a0;with&#x000a0;prolonged QRS duration&#x000a0;from TOF repair. These factors increase the incidence of atrial and ventricular arrhythmias, which are a major risk for mortality.<xref ref-type="bibr" rid="article-30004.r23">[23]</xref>&#x000a0;Those rarely encountered patients who did not undergo surgical repair&#x000a0;may have complications of chronic hypoxemia such as hyperviscosity, abnormal hemostasis, stroke, cerebral abscess, and endocarditis.<xref ref-type="bibr" rid="article-30004.r13">[13]</xref><xref ref-type="bibr" rid="article-30004.r24">[24]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-30004.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Chest radiography, electrocardiogram, and an echocardiogram are the primary imaging studies utilized to diagnose TOF. Typical findings on chest radiography include a normal-size heart silhouette with an upturned apex and a concave or "boot-shaped" main pulmonary artery segment (see <bold>Image.</bold>&#x000a0;Chest X-ray of&#x000a0;Tetralogy of Fallot).&#x000a0;Right axis deviation, prominent R or qR waves in V1, and upright T waves in V1, characteristic&#x000a0;of right atrial enlargement and right ventricular hypertrophy, are common on the electrocardiogram.&#x000a0;</p>
        <p>The echocardiogram is the gold standard for the diagnosis of TOF. This noninvasive modality is used at the patient's bedside to accurately assess the anatomy and severity of the RVOTO, the location and number of VSDs, associated anomalies, aortic arch, and coronary artery variants since RVOT crossing of coronary arteries will complicate the surgical approach. The major limitation of the transesophageal echocardiogram in patients with&#x000a0;TOF is visualizing the distal pulmonary arteries.<xref ref-type="bibr" rid="article-30004.r19">[19]</xref></p>
        <p>Cardiac magnetic resonance imaging (MRI) or cardiac computed tomography (CT) can be used, particularly in adults with repaired TOF. These noninvasive imaging modalities have made diagnostic cardiac catheterization no longer a routine&#x000a0;for patients with classic TOF anatomy. However, cardiac catheterization can&#x000a0;still be used to&#x000a0;assess the level and degree of RVOTO, pulmonary stenosis or hypoplasia, distal branch pulmonary artery anatomy, and coronary artery anatomy. It can delineate&#x000a0;aortopulmonary collaterals when present and&#x000a0;show accessory septal defects best seen with a left ventricular injection. Cardiac catheterization can also be used in selected patients for ductal and RVOT stenting. Knowing that&#x000a0;catheter manipulation can trigger a hypercyanotic or "tet spell" and should thus be used when strictly necessary is essential.<xref ref-type="bibr" rid="article-30004.r19">[19]</xref></p>
      </sec>
      <sec id="article-30004.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Neonates with severe&#x000a0;RVOTO who present with profound hypoxemia and cyanosis&#x000a0;will&#x000a0;require prostaglandin therapy to maintain ductal patency and adequate pulmonary blood flow before a transcatheter intervention or surgical repair. Tet spells require a rapid and aggressive approach, including knee-chest positioning to increase systemic vascular resistance and "force" more blood into the pulmonary artery, oxygen therapy to cause pulmonary vasodilation, and decrease pulmonary vascular resistance. Patients may require intravenous fluid boluses to improve&#x000a0;RV&#x000a0;filling and increase pulmonary blood flow. They may also need intravenous beta-blockers to decrease heart rate to aid RV filling further and, sometimes, intravenous phenylephrine to increase systemic afterload. Morphine can also be given as a sedative during a tet spell, alleviating&#x000a0;pain and anxiety and helping decrease heart and respiratory rates. A tet spell, left untreated, may lead to loss of consciousness and, ultimately, death.<xref ref-type="bibr" rid="article-30004.r25">[25]</xref><xref ref-type="bibr" rid="article-30004.r26">[26]</xref><xref ref-type="bibr" rid="article-30004.r27">[27]</xref>&#x000a0;</p>
        <p>Without surgical treatment, the survival rate of patients with TOF without additional cardiac defects is approximately 66% at 1 year of age, 40% at 3 years, 11% at 20 years, 6% at 30 years, and 3% at 40 years.<xref ref-type="bibr" rid="article-30004.r13">[13]</xref>&#x000a0;Surgical or transcatheter palliation and surgical repair aim to provide adequate and stable pulmonary blood flow. The timing of TOF repair is still in debate, with some centers advocating neonatal repair&#x000a0;with better&#x000a0;results than systemic-to-pulmonary artery shunting, deferring the complete surgical repair to after the first 3 months of life. The&#x000a0;technique involves placing a "modified" Blalock-Taussig shunt graft between the subclavian artery and the ipsilateral branch pulmonary artery.<xref ref-type="bibr" rid="article-30004.r8">[8]</xref></p>
        <p>Reasons&#x000a0;for an initial surgical palliative shunting include&#x000a0;technical difficulties in the systemic-to-pulmonary shunt placement due to the smaller pulmonary arteries&#x000a0;of the newborn, decreased postoperative mortality after the neonatal period,&#x000a0;unfavorable coronary artery anatomy with a large branch crossing the RVOT&#x000a0;that will require a&#x000a0;right ventricle to pulmonary artery conduit, which is safer to operate in the larger heart&#x000a0;of an older infant, and the surgeon's preference.<xref ref-type="bibr" rid="article-30004.r19">[19]</xref><xref ref-type="bibr" rid="article-30004.r28">[28]</xref>&#x000a0;Stenting of the ductus arteriosus&#x000a0;with or without RVOT stenting with pulmonary artery banding is a less invasive alternative to surgical palliation, as&#x000a0;it does not require cardiopulmonary bypass with the additional advantage of not requiring a sternotomy or thoracotomy.<xref ref-type="bibr" rid="article-30004.r29">[29]</xref>&#x000a0;</p>
        <p>When possible, earlier techniques of transannular patching and ventriculotomy&#x000a0;are&#x000a0;being replaced by right atrial atriotomy and operation through the tricuspid valve, limiting the transannular incision.<xref ref-type="bibr" rid="article-30004.r1">[1]</xref>&#x000a0;During the VSD closure, care is taken to avoid injuring the His bundle, which would produce an atrioventricular conduction block. Reduced&#x000a0;RV compliance may require leaving or creating a minor atrial septal defect to allow right atrial decompression at the expense of residual cyanosis.<xref ref-type="bibr" rid="article-30004.r19">[19]</xref></p>
        <p>An RV to pulmonary artery conduit is used in patients with TOF and pulmonary atresia in the presence of a markedly hypoplastic or atretic RVOT or a sizeable conal branch coronary artery crossing the RVOT. Pulmonary artery conduits are also used in those requiring reoperation for severe pulmonary insufficiency or recurrent stenosis. These conduits&#x000a0;include pulmonary or aortic homografts, heterografts (ie, bovine jugular vein grafts), or autologous pericardial valved conduits. However, they have a limited lifespan, requiring reoperation within a few years.<xref ref-type="bibr" rid="article-30004.r30">[30]</xref>&#x000a0;</p>
        <p>Patients with TOF&#x000a0;and pulmonary atresia&#x000a0;with major aortopulmonary collaterals (MAPCAs) might require prostaglandin E1 in the early neonatal period if these collaterals are not sufficiently developed. These patients can undergo early complete repair with segmental pulmonary artery reconstruction&#x000a0;in the neonatal period incorporating all lung segments, or they can undergo a staged repair with initial unifocalization of the MAPCAs followed by intracardiac TOF repair at 4 to 7 months of age.<xref ref-type="bibr" rid="article-30004.r31">[31]</xref></p>
        <p>Patients with TOF and absent pulmonary valves require plication and reduction of the size of the pulmonary arteries with or without suspension of the left pulmonary artery to the anterior chest wall to relieve bronchial compression, in addition to the intracardiac patch closure of the VSD. Another surgical technique is to transect the ascending aorta and anteriorly move the right pulmonary artery. Some undergo placement of a valved RV to pulmonary artery conduit to place a functioning pulmonary valve. Airway stenting is rarely indicated and reserved for those with severe airway obstruction despite surgery.<xref ref-type="bibr" rid="article-30004.r32">[32]</xref>&#x000a0;Early extubation will improve&#x000a0;cardiac preload and RV filling, improving cardiac output.<xref ref-type="bibr" rid="article-30004.r19">[19]</xref></p>
      </sec>
      <sec id="article-30004.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>&#x0201c;Tet spells&#x0201d; can present with respiratory distress and worsening cyanosis. This clinical scenario can also&#x000a0;be observed with other cardiac malformations&#x000a0;with right-to-left shunting, including complete transposition of the great arteries (d-TGA) with pulmonary stenosis, double outlet right ventricle with severe pulmonary stenosis, tricuspid atresia, and Ebstein anomaly. Isolated severe pulmonic or aortic stenosis can produce a similar clinical picture. Viral or bacterial infections such as bronchiolitis or pneumonia can also be included as a differential diagnosis and pneumothorax.&#x000a0;</p>
      </sec>
      <sec id="article-30004.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Although current surgical mortality&#x000a0;can be as low as 2%, with 20-year survival exceeding 90%, most patients&#x000a0;will&#x000a0;develop residual hemodynamic and electrophysiologic abnormalities, especially after the third decade of life.<xref ref-type="bibr" rid="article-30004.r33">[33]</xref> Pulmonary regurgitation, which results from the reconstruction of the RVOT, produces RV dilatation, dysfunction, and&#x000a0;diffuse interstitial fibrosis&#x000a0;that perpetuates the dysfunction.<xref ref-type="bibr" rid="article-30004.r34">[34]</xref><xref ref-type="bibr" rid="article-30004.r35">[35]</xref><xref ref-type="bibr" rid="article-30004.r36">[36]</xref><xref ref-type="bibr" rid="article-30004.r37">[37]</xref><xref ref-type="bibr" rid="article-30004.r34">[34]</xref> The RV dysfunction affects the left ventricle via abnormal ventricular interaction&#x000a0;from shared myofibers, creating electromechanical dyssynchrony.<xref ref-type="bibr" rid="article-30004.r38">[38]</xref><xref ref-type="bibr" rid="article-30004.r39">[39]</xref>&#x000a0;</p>
        <p>Conventional practice has been that a QRS duration greater than 180 msec, sustained ventricular tachycardia, and a history of syncope are associated with exercise intolerance,&#x000a0;cardiac failure, and death in these patients.<xref ref-type="bibr" rid="article-30004.r23">[23]</xref><xref ref-type="bibr" rid="article-30004.r34">[34]</xref><xref ref-type="bibr" rid="article-30004.r40">[40]</xref>&#x000a0;However,&#x000a0;a very&#x000a0;recent study in&#x000a0;adults with repaired TOF&#x000a0;observed that the highest mortality risk appears to be related to any of the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Age younger than 50 years</p>
          </list-item>
          <list-item>
            <p>Findings on cardiac magnetic resonance imaging (MRI)
<list list-type="bullet"><list-item><p>Extensive RV and LV&#x000a0;late gadolinium enhancement, which confirms the presence of extensive collagen deposition or fibrosis</p></list-item><list-item><p>RV ejection fraction of&#x000a0;&#x02264;35%</p></list-item><list-item><p>LV ejection fraction&#x000a0;&#x02264;35%</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Peak oxygen uptake&#x000a0;&#x02264;17 mL/kg/m<sup>2</sup></p>
          </list-item>
          <list-item>
            <p>B-type natriuretic peptide&#x000a0;&#x02265;127 ng/L</p>
          </list-item>
          <list-item>
            <p>Sustained atrial arrhythmias&#x000a0;<xref ref-type="bibr" rid="article-30004.r41">[41]</xref></p>
          </list-item>
        </list>
        <p>Atrial tachyarrhythmias, usually intra-atrial reentrant tachycardia and cavotricuspid isthmus-dependent atrial flutter, can be observed with advancing age after TOF repair and comprise up to 20% of the arrhythmias observed in these patients. Large right atrial size, sinus node dysfunction, and at least moderate tricuspid regurgitation are associated with atrial arrhythmias. Atrial fibrillation is more commonly associated with older patient age, decreased left ventricular function, left atrial dilatation, hypertension, and multiple cardiac surgeries.<xref ref-type="bibr" rid="article-30004.r42">[42]</xref>&#x000a0;Atrial arrhythmias&#x000a0;have been recently&#x000a0;recognized to be associated with severe adverse events in adult patients who had TOF repair.<xref ref-type="bibr" rid="article-30004.r43">[43]</xref></p>
        <p>The prognosis of these patients is also affected by the need for pulmonary valve replacement due to&#x000a0;progressive&#x000a0;pulmonary insufficiency, which places them at risk of bacterial endocarditis.<xref ref-type="bibr" rid="article-30004.r24">[24]</xref>&#x000a0;Very recently, a multinational, multicenter study demonstrated for the first time that pulmonary valve replacement (PVR) in patients with repaired TOF is associated with a lower probability of sustained ventricular tachycardia (VT) and death, especially in those patients with more severe RV volume overload from pulmonary insufficiency, who are at high risk of developing mechanoelectrical cardiomyopathy. The study, however, did not determine the best timing for PVR or whether surgery or transcatheter pulmonary valve placement yields better results.<xref ref-type="bibr" rid="article-30004.r44">[44]</xref></p>
      </sec>
      <sec id="article-30004.s11" sec-type="Complications">
        <title>Complications</title>
        <p>
<bold>Short Term Complications</bold>
</p>
        <p>Palliative surgery to place a modified Blalock-Taussig shunt poses the risk of recurrent laryngeal and phrenic nerve damage. In addition, shunt size might create inadequate or excessive pulmonary blood flow, leading to either pulmonary overcirculation/congestive heart failure (CHF) and failure to thrive or cyanosis, respectively.<xref ref-type="bibr" rid="article-30004.r19">[19]</xref> Shunt thrombosis can be life-threatening and will require urgent reoperation, interventional catheterization for direct thrombolysis, or, if all fail, extracorporeal membrane oxygenation (ECMO).<xref ref-type="bibr" rid="article-30004.r45">[45]</xref>&#x000a0;</p>
        <p>Complications&#x000a0;within the immediate postoperative period after complete TOF repair include pericardial and pleural effusion requiring drainage, chylothorax, bleeding requiring reoperation, superficial wound infection, moderate pulmonary regurgitation in up to 14% of patients, residual ventricular septal defects with persistent hypoxemia,&#x000a0;and RVOTO.<xref ref-type="bibr" rid="article-30004.r46">[46]</xref></p>
        <p>Junctional ectopic tachycardia (JET) can occur in approximately 15% to 20% of patients in the immediate postoperative period,&#x000a0;causing a low cardiac output with profound hypotension and hemodynamic instability. Treatment&#x000a0;may include correction of any electrolyte imbalance, cooling the patient (hypothermia), decreasing vasoactive drugs such as dopamine, atrial pacing over the ventricular rate to restore atrioventricular synchrony, increasing sedation to control pain (ie, dexmedetomidine infusion), magnesium sulfate, and antiarrhythmics such as amiodarone, procainamide, or esmolol.&#x000a0;Nonresponders may require ECMO until the arrhythmia subsides and cardiac output can be maintained.<xref ref-type="bibr" rid="article-30004.r47">[47]</xref><xref ref-type="bibr" rid="article-30004.r48">[48]</xref><xref ref-type="bibr" rid="article-30004.r47">[47]</xref>&#x000a0;Significant predictors for the development of postoperative JET include&#x000a0;a patient&#x000a0;younger&#x000a0;than 6 months of age and&#x000a0;postoperative use of inotropes such as dopamine.<xref ref-type="bibr" rid="article-30004.r49">[49]</xref></p>
        <p>Patients&#x000a0;undergoing a transatrial-transpulmonary approach appear to have fewer tachyarrhythmias and virtually no permanent pacemaker requirement&#x000a0;for postoperative conduction abnormalities in the early postoperative period compared to those&#x000a0;receiving&#x000a0;a right ventriculotomy.<xref ref-type="bibr" rid="article-30004.r46">[46]</xref>&#x000a0;Damage to the conduction system can occur, with&#x000a0;RBBB occurring frequently, bifascicular block in 8% to 12% of patients, and complete atrioventricular block in 3% to 5%. Poor RV compliance is another postoperative complication, resulting from the combination of RV hypertrophy&#x000a0;and diastolic dysfunction with uncoordinated RV contraction from damage to the conduction system and the creation of a transannular patch with resection of contractile muscle fibers that a non-contractile patch on the RV free wall has replaced. Management of RV dysfunction in the immediate postoperative period may require beta-agonist avoidance, beta-blocker use, and&#x000a0;monitoring&#x000a0;fluid balance.<xref ref-type="bibr" rid="article-30004.r19">[19]</xref></p>
        <p>Arrhythmias can&#x000a0;occur after TOF repair, including ventricular tachycardia, atrial fibrillation or flutter, and intra-atrial reentrant tachycardia. Risk factors for ventricular arrhythmias and sudden cardiac death include older age at repair, male gender, transient complete heart block beyond postoperative day 3, and QRS duration greater than 180 milliseconds.<xref ref-type="bibr" rid="article-30004.r50">[50]</xref>&#x000a0;Prematurity is associated with higher postoperative mortality risk.<xref ref-type="bibr" rid="article-30004.r46">[46]</xref>&#x000a0;The incidence of postoperative moderate to severe pulmonary regurgitation has decreased due to valve-sparing techniques.<xref ref-type="bibr" rid="article-30004.r46">[46]</xref>&#x000a0;</p>
        <p>
<bold>Long-Term Complications</bold>
</p>
        <p>Adult patients with&#x000a0;CHD are increasing in prevalence by an approximate estimate of 5% per year, surpassing the pediatric population. Thus, long-term complications from the surgical repair or CHD must be acknowledged.&#x000a0;The progressive nature of pulmonary regurgitation despite valve-sparing techniques is well recognized, with a cumulative incidence of 40% at 35 years of age after TOF repair.<xref ref-type="bibr" rid="article-30004.r51">[51]</xref><xref ref-type="bibr" rid="article-30004.r46">[46]</xref><xref ref-type="bibr" rid="article-30004.r51">[51]</xref>&#x000a0;The most common indication for reoperation is pulmonary insufficiency. Long-term consequences include&#x000a0;RV volume overload from pulmonary insufficiency and right and left ventricular dysfunction.<xref ref-type="bibr" rid="article-30004.r39">[39]</xref>&#x000a0;Pulmonary valve replacement&#x000a0;can be achieved surgically or by a transcatheter approach.<xref ref-type="bibr" rid="article-30004.r52">[52]</xref>&#x000a0;</p>
        <p>Other long-term complications include RV&#x000a0;aneurysm from&#x000a0;the outflow patch or the ventriculotomy, distal pulmonary artery obstruction, ventricular hypertrophy, and aortic root dilation and insufficiency. Patients can have exercise intolerance, which can be aggravated by concomitant ventricular dyssynchrony and signs and symptoms of CHF.<xref ref-type="bibr" rid="article-30004.r23">[23]</xref> An aortic root dilatation &#x0003e;55 cm with aortic insufficiency warrants aortic root surgery.<xref ref-type="bibr" rid="article-30004.r20">[20]</xref>&#x000a0;Patients with TOF, repaired or unrepaired, are at risk of endocarditis and should receive SBE prophylaxis before any dental or elective surgical procedure.<xref ref-type="bibr" rid="article-30004.r13">[13]</xref></p>
        <p>Leading causes of mortality in patients with repaired&#x000a0;TOF include late arrhythmias (ventricular and atrial), heart failure, and complications from reoperations. Forty to 50% of adults with repaired TOF can have ventricular arrhythmias, including sustained ventricular tachycardia with syncope.&#x000a0;The risk of sudden death&#x000a0;ranges between 6% to 9% 30 years&#x000a0;after the surgical procedure. Some factors associated with this risk are QRS duration greater than 180 milliseconds, older age at repair, especially older than 3 years, significant pulmonary valve or tricuspid valve regurgitation, history of syncope, multifocal premature ventricular contractions, and&#x000a0;presence of ventricular tachycardia.<xref ref-type="bibr" rid="article-30004.r11">[11]</xref>&#x000a0;</p>
        <p>Atrial flutter and fibrillation become increasingly prevalent with advancing age in the TOF population, causing substantial morbidity.<xref ref-type="bibr" rid="article-30004.r13">[13]</xref>&#x000a0;Larger right atrial size and at least moderate tricuspid regurgitation are associated with such atrial tachyarrhythmias. Additionally, atrial tachyarrhythmias frequently occur concomitantly with sinus node dysfunction and may perpetuate each other.<xref ref-type="bibr" rid="article-30004.r42">[42]</xref>&#x000a0;Those with RV to pulmonary artery conduits who reach adulthood are also at increased risk of death or sustained ventricular tachycardia.<xref ref-type="bibr" rid="article-30004.r33">[33]</xref>&#x000a0;&#x000a0;Among adults with CHD, acquired cardiac disease secondary to metabolic syndrome, hypertension, obesity, and diabetes type 2 are&#x000a0;leading causes of&#x000a0;morbidity and mortality.<xref ref-type="bibr" rid="article-30004.r53">[53]</xref></p>
        <p>Patients with CHD, in general, are known to be at risk for neurodevelopmental disability from underlying syndromes, genetic or developmental disorders, and medical and surgical therapies. These patients usually present mild cognitive impairment, impaired communication skills and social interaction, inattention, impulsivity, and impaired executive function. Tutoring, special education, and physical, occupational, and speech therapy are frequently required, with a significant proportion of patients needing these services into adulthood. These issues may limit their educational achievements, employability, insurability, and quality of life.<xref ref-type="bibr" rid="article-30004.r54">[54]</xref></p>
        <p>
<bold>Pregnancy Complications</bold>
</p>
        <p>Women who had correction of TOF are expected to&#x000a0;have similar outcomes&#x000a0;as the general obstetric population. Pregnancy complications are related to the&#x000a0;degree of pulmonary hypertension, the severity of pulmonary regurgitation, and the magnitude of right&#x000a0;and left ventricular dysfunction. Maternal cardiovascular events can include arrhythmias requiring treatment (eg, atrial flutter or fibrillation, ventricular tachycardia, cardiac failure during the third trimester, and pulmonary embolism). Offspring complications have been described, such as small for gestational age, prematurity, intrauterine demise, and increased incidence of CHD such as atrial septal defect, TOF, and atrioventricular septal defect.<xref ref-type="bibr" rid="article-30004.r55">[55]</xref>&#x000a0;</p>
        <p>Patients&#x000a0;with moderate&#x000a0;RV hypertension&#x000a0;and those who had a palliative shunt&#x000a0;are at an increased risk for cardiac events during pregnancy and miscarriage. Pregnancy in the setting of unrepaired TOF carries the risk of progressive RV dilatation and congestive heart failure, atrial and ventricular arrhythmias, postpartum hemorrhage, and progressive aortic root dilatation. Maternal causes of death in this patient population include pulmonary hemorrhage, thromboembolism, and brain abscess. Obstetric complications include prematurity, low birth weight, and increased risk of miscarriage.<xref ref-type="bibr" rid="article-30004.r56">[56]</xref></p>
        <p>
<bold>Mortality in Unrepaired Tetralogy of Fallot</bold>
</p>
        <p>The most frequent causes of mortality in patients with no surgical intervention include hypoxic spells (68%), cerebrovascular accidents (17%), and brain abscesses (13%). Within the first year of life, 25% of infants with severe RVOTO die if left untreated, 40% by 3 years of age, 70% by 10 years of age, and 95% by 40 years of age.<xref ref-type="bibr" rid="article-30004.r57">[57]</xref><xref ref-type="bibr" rid="article-30004.r58">[58]</xref></p>
      </sec>
      <sec id="article-30004.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Due to advances in surgical correction, TOF&#x000a0;is not an uncommon diagnosis among the adult congenital heart disease population. As these patients age, they may require reoperation or transcatheter pulmonary valve replacement, arrhythmia treatment, and lifestyle modification to prevent cardiovascular disease secondary to dyslipidemia and diabetes.<xref ref-type="bibr" rid="article-30004.r15">[15]</xref><xref ref-type="bibr" rid="article-30004.r59">[59]</xref><xref ref-type="bibr" rid="article-30004.r52">[52]</xref></p>
        <p>Most patients ' exercise capacity, measured as peak oxygen uptake and heart rate, is limited after TOF repair. However,&#x000a0;patients can participate in all forms of physical activity with individualized guidelines. However, restriction from competitive sports is recommended for TOF patients with severe ventricular dysfunction (ie, EF &#x0003c;40%), severe outflow tract obstruction, or recurrent atrial or ventricular arrhythmias, with the possible exception of low-intensity activities.<xref ref-type="bibr" rid="article-30004.r20">[20]</xref><xref ref-type="bibr" rid="article-30004.r60">[60]</xref></p>
        <p>Pregnancy&#x000a0;is generally well tolerated&#x000a0;in women with TOF&#x000a0;with good underlying hemodynamics. However, in women with important RVOT obstruction, severe pulmonary and or tricuspid regurgitation, as well as right and left ventricular dysfunction, the increased volume load&#x000a0;during pregnancy&#x000a0;can precipitate RV&#x000a0;failure and arrhythmias.<xref ref-type="bibr" rid="article-30004.r61">[61]</xref>&#x000a0;There is also a higher incidence of cesarean section, miscarriage, preterm births (14%), and small gestational-age&#x000a0;newborns (10%). Therefore, these patients are usually regarded as&#x000a0;low to moderate risk. In addition,&#x000a0;the chances of producing a fetus with a congenital heart defect are higher than among the general population.<xref ref-type="bibr" rid="article-30004.r62">[62]</xref><xref ref-type="bibr" rid="article-30004.r63">[63]</xref><xref ref-type="bibr" rid="article-30004.r62">[62]</xref></p>
      </sec>
      <sec id="article-30004.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The diagnosis and management of TOF&#x000a0;require an interprofessional team, including&#x000a0;pediatric cardiologist specialists (ie, imaging, interventionist, and electrophysiologist), neonatologists, intensivists, pediatric cardiac surgeons, respiratory therapists, nurses, geneticists, nutritionists, physical and occupational therapists, psychologists or family therapists.<xref ref-type="bibr" rid="article-30004.r54">[54]</xref></p>
        <p>In general, patients&#x000a0;with TOF require several surgeries.&#x000a0;Pulmonary valve replacement via surgical or transcatheter approach will eventually be necessary during early adulthood. These patients require lifelong subacute bacterial endocarditis prophylaxis.<xref ref-type="bibr" rid="article-30004.r64">[64]</xref>&#x000a0;Most patients will also require&#x000a0;services to help with their neurodevelopmental disabilities, which are being increasingly recognized in patients with CHD. Should a woman with TOF reach childbearing age and decide to become pregnant, a professional team including obstetricians, high-risk perinatologists, adult congenital cardiologists, adult congenital interventionists, and electrophysiologists, as well as pediatric cardiac surgeons, will be required to assist throughout the pregnancy, peripartum and postpartum period.<xref ref-type="bibr" rid="article-30004.r65">[65]</xref></p>
      </sec>
      <sec id="article-30004.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30004&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30004">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/heart-health/tetralogy-of-fallot/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=30004">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/30004/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=30004">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-30004.s15">
        <fig id="article-30004.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Tetralogy of Fallot. The diagram shows a healthy heart on the left and a heart with the 4 anatomic malformations characteristic of the Tetralogy of Fallot on the right. Mariana Ruiz, Public Domain, via <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://commons.wikimedia.org/wiki/Main_Page">Wikimedia Commons</ext-link>.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Tetralogy_of_Fallot.svg" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-30004.s16">
        <fig id="article-30004.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Chest X-ray of Tetralogy of Fallot Contributed by S Bhimji, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="TOF3" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-30004.s17">
        <title>References</title>
        <ref id="article-30004.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barron</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Tetralogy of Fallot: controversies in early management.</article-title>
            <source>World J Pediatr Congenit Heart Surg</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>4</volume>
            <issue>2</issue>
            <fpage>186</fpage>
            <page-range>186-91</page-range>
            <pub-id pub-id-type="pmid">23799733</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bailliard</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>RH</given-names>
              </name>
            </person-group>
            <article-title>Tetralogy of Fallot.</article-title>
            <source>Orphanet J Rare Dis</source>
            <year>2009</year>
            <month>Jan</month>
            <day>13</day>
            <volume>4</volume>
            <fpage>2</fpage>
            <pub-id pub-id-type="pmid">19144126</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Karl</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Stocker</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Tetralogy of Fallot and Its Variants.</article-title>
            <source>Pediatr Crit Care Med</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>17</volume>
            <issue>8 Suppl 1</issue>
            <fpage>S330</fpage>
            <page-range>S330-6</page-range>
            <pub-id pub-id-type="pmid">27490619</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bittel</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Butler</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Kibiryeva</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Marshall</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lofland</surname>
                <given-names>GK</given-names>
              </name>
              <name>
                <surname>O'Brien</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Gene expression in cardiac tissues from infants with idiopathic conotruncal defects.</article-title>
            <source>BMC Med Genomics</source>
            <year>2011</year>
            <month>Jan</month>
            <day>05</day>
            <volume>4</volume>
            <fpage>1</fpage>
            <pub-id pub-id-type="pmid">21208432</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matos-Nieves</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yasuhara</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Another Notch in the Genetic Puzzle of Tetralogy of Fallot.</article-title>
            <source>Circ Res</source>
            <year>2019</year>
            <month>Feb</month>
            <day>15</day>
            <volume>124</volume>
            <issue>4</issue>
            <fpage>462</fpage>
            <page-range>462-464</page-range>
            <pub-id pub-id-type="pmid">30763217</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Page</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Miossec</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Monaghan</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Fotiou</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cordell</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Sutcliffe</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Topf</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bourgey</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bourque</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Eveleigh</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Dunwoodie</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Winlaw</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Bhattacharya</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Breckpot</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Devriendt</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gewillig</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Brook</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Setchfield</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Bu'Lock</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>O'Sullivan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Stuart</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bezzina</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Mulder</surname>
                <given-names>BJM</given-names>
              </name>
              <name>
                <surname>Postma</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Bentham</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Baron</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bhaskar</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Black</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Newman</surname>
                <given-names>WG</given-names>
              </name>
              <name>
                <surname>Hentges</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Lathrop</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Santibanez-Koref</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Keavney</surname>
                <given-names>BD</given-names>
              </name>
            </person-group>
            <article-title>Whole Exome Sequencing Reveals the Major Genetic Contributors to Nonsyndromic Tetralogy of Fallot.</article-title>
            <source>Circ Res</source>
            <year>2019</year>
            <month>Feb</month>
            <day>15</day>
            <volume>124</volume>
            <issue>4</issue>
            <fpage>553</fpage>
            <page-range>553-563</page-range>
            <pub-id pub-id-type="pmid">30582441</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chung</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Rajakumar</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Genetics of Congenital Heart Defects: The NKX2-5 Gene, a Key Player.</article-title>
            <source>Genes (Basel)</source>
            <year>2016</year>
            <month>Jan</month>
            <day>23</day>
            <volume>7</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">26805889</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Villafa&#x000f1;e</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Feinstein</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Jenkins</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Vincent</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Dubin</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Geva</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Towbin</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Fraser</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dearani</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rosenthal</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kaufman</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Graham</surname>
                <given-names>TP</given-names>
              </name>
              <collab>Adult&#x000a0;Congenital and Pediatric Cardiology Section, American College of Cardiology</collab>
            </person-group>
            <article-title>Hot topics in tetralogy of Fallot.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2013</year>
            <month>Dec</month>
            <day>10</day>
            <volume>62</volume>
            <issue>23</issue>
            <fpage>2155</fpage>
            <page-range>2155-66</page-range>
            <pub-id pub-id-type="pmid">24076489</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pierpont</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Basson</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Benson</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Gelb</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Giglia</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Goldmuntz</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>McGee</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sable</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Srivastava</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Webb</surname>
                <given-names>CL</given-names>
              </name>
              <collab>American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young</collab>
            </person-group>
            <article-title>Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics.</article-title>
            <source>Circulation</source>
            <year>2007</year>
            <month>Jun</month>
            <day>12</day>
            <volume>115</volume>
            <issue>23</issue>
            <fpage>3015</fpage>
            <page-range>3015-38</page-range>
            <pub-id pub-id-type="pmid">17519398</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pierpont</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Brueckner</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>WK</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Lacro</surname>
                <given-names>RV</given-names>
              </name>
              <name>
                <surname>McGuire</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Mital</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Priest</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Pu</surname>
                <given-names>WT</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ware</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Gelb</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Russell</surname>
                <given-names>MW</given-names>
              </name>
              <collab>American Heart Association Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Genomic and Precision Medicine</collab>
            </person-group>
            <article-title>Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association.</article-title>
            <source>Circulation</source>
            <year>2018</year>
            <month>Nov</month>
            <day>20</day>
            <volume>138</volume>
            <issue>21</issue>
            <fpage>e653</fpage>
            <page-range>e653-e711</page-range>
            <pub-id pub-id-type="pmid">30571578</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wu</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Kao</surname>
                <given-names>FY</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>SK</given-names>
              </name>
            </person-group>
            <article-title>Adult Congenital Heart Disease in a Nationwide Population 2000-2014: Epidemiological Trends, Arrhythmia, and Standardized Mortality Ratio.</article-title>
            <source>J Am Heart Assoc</source>
            <year>2018</year>
            <month>Feb</month>
            <day>08</day>
            <volume>7</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">29437602</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bertranou</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Blackstone</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Hazelrig</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Turner</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Kirklin</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Life expectancy without surgery in tetralogy of Fallot.</article-title>
            <source>Am J Cardiol</source>
            <year>1978</year>
            <month>Sep</month>
            <volume>42</volume>
            <issue>3</issue>
            <fpage>458</fpage>
            <page-range>458-66</page-range>
            <pub-id pub-id-type="pmid">685856</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brickner</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Hillis</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Lange</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Congenital heart disease in adults. Second of two parts.</article-title>
            <source>N Engl J Med</source>
            <year>2000</year>
            <month>Feb</month>
            <day>03</day>
            <volume>342</volume>
            <issue>5</issue>
            <fpage>334</fpage>
            <page-range>334-42</page-range>
            <pub-id pub-id-type="pmid">10655533</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>O'Brien</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Marshall</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>Cardiology patient page. Tetralogy of Fallot.</article-title>
            <source>Circulation</source>
            <year>2014</year>
            <month>Jul</month>
            <day>22</day>
            <volume>130</volume>
            <issue>4</issue>
            <fpage>e26</fpage>
            <page-range>e26-9</page-range>
            <pub-id pub-id-type="pmid">25047589</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Diller</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Kempny</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Liodakis</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Alonso-Gonzalez</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Inuzuka</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Uebing</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Orwat</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dimopoulos</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Swan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Gatzoulis</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Baumgartner</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Left ventricular longitudinal function predicts life-threatening ventricular arrhythmia and death in adults with repaired tetralogy of fallot.</article-title>
            <source>Circulation</source>
            <year>2012</year>
            <month>May</month>
            <day>22</day>
            <volume>125</volume>
            <issue>20</issue>
            <fpage>2440</fpage>
            <page-range>2440-6</page-range>
            <pub-id pub-id-type="pmid">22496160</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mongeon</surname>
                <given-names>FP</given-names>
              </name>
              <name>
                <surname>Gurvitz</surname>
                <given-names>MZ</given-names>
              </name>
              <name>
                <surname>Broberg</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Aboulhosn</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Opotowsky</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Kay</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Valente</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Earing</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Lui</surname>
                <given-names>GK</given-names>
              </name>
              <name>
                <surname>Fernandes</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Gersony</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Cook</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Ting</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Nickolaus</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Landzberg</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Khairy</surname>
                <given-names>P</given-names>
              </name>
              <collab>Alliance for Adult Research in Congenital Cardiology (AARCC)</collab>
            </person-group>
            <article-title>Aortic root dilatation in adults with surgically repaired tetralogy of fallot: a multicenter cross-sectional study.</article-title>
            <source>Circulation</source>
            <year>2013</year>
            <month>Jan</month>
            <day>15</day>
            <volume>127</volume>
            <issue>2</issue>
            <fpage>172</fpage>
            <page-range>172-9</page-range>
            <pub-id pub-id-type="pmid">23224208</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van der Ven</surname>
                <given-names>JPG</given-names>
              </name>
              <name>
                <surname>van den Bosch</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bogers</surname>
                <given-names>AJCC</given-names>
              </name>
              <name>
                <surname>Helbing</surname>
                <given-names>WA</given-names>
              </name>
            </person-group>
            <article-title>Current outcomes and treatment of tetralogy of Fallot.</article-title>
            <source>F1000Res</source>
            <year>2019</year>
            <volume>8</volume>
            <pub-id pub-id-type="pmid">31508203</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salazar</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Newth</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Khemani</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>J&#x000fc;rg</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ross</surname>
                <given-names>PA</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary function testing in infants with tetralogy of Fallot and absent pulmonary valve syndrome.</article-title>
            <source>Ann Pediatr Cardiol</source>
            <year>2015</year>
            <season>May-Aug</season>
            <volume>8</volume>
            <issue>2</issue>
            <fpage>108</fpage>
            <page-range>108-12</page-range>
            <pub-id pub-id-type="pmid">26085760</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wise-Faberowski</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Asija</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>McElhinney</surname>
                <given-names>DB</given-names>
              </name>
            </person-group>
            <article-title>Tetralogy of Fallot: Everything you wanted to know but were afraid to ask.</article-title>
            <source>Paediatr Anaesth</source>
            <year>2019</year>
            <month>May</month>
            <volume>29</volume>
            <issue>5</issue>
            <fpage>475</fpage>
            <page-range>475-482</page-range>
            <pub-id pub-id-type="pmid">30592107</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Apitz</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Webb</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Redington</surname>
                <given-names>AN</given-names>
              </name>
            </person-group>
            <article-title>Tetralogy of Fallot.</article-title>
            <source>Lancet</source>
            <year>2009</year>
            <month>Oct</month>
            <day>24</day>
            <volume>374</volume>
            <issue>9699</issue>
            <fpage>1462</fpage>
            <page-range>1462-71</page-range>
            <pub-id pub-id-type="pmid">19683809</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chelliah</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Moon-Grady</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Peyvandi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chiu</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Bost</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Schidlow</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Carroll</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Davey</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Divanovic</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hornberger</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Howley</surname>
                <given-names>LW</given-names>
              </name>
              <name>
                <surname>Kavanaugh-McHugh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kovalchin</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Levasseur</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Lindblade</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Morris</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Ngwezi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pruetz</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Puchalski</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Rychik</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Samai</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tacy</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Tworetzky</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Vernon</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Yeh</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Donofrio</surname>
                <given-names>MT</given-names>
              </name>
            </person-group>
            <article-title>Contemporary Outcomes in Tetralogy of Fallot With Absent Pulmonary Valve After Fetal Diagnosis.</article-title>
            <source>J Am Heart Assoc</source>
            <year>2021</year>
            <month>Jun</month>
            <day>15</day>
            <volume>10</volume>
            <issue>12</issue>
            <fpage>e019713</fpage>
            <pub-id pub-id-type="pmid">34098741</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Recker</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Weber</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Strizek</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Geipel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Berg</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gembruch</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Management and outcome of prenatal absent pulmonary valve syndrome.</article-title>
            <source>Arch Gynecol Obstet</source>
            <year>2022</year>
            <month>Nov</month>
            <volume>306</volume>
            <issue>5</issue>
            <fpage>1449</fpage>
            <page-range>1449-1454</page-range>
            <pub-id pub-id-type="pmid">35043273</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lumens</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fan</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Walmsley</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yim</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Manlhiot</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dragulescu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Grosse-Wortmann</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mertens</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Prinzen</surname>
                <given-names>FW</given-names>
              </name>
              <name>
                <surname>Delhaas</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Friedberg</surname>
                <given-names>MK</given-names>
              </name>
            </person-group>
            <article-title>Relative Impact of Right Ventricular Electromechanical Dyssynchrony Versus Pulmonary Regurgitation on Right Ventricular Dysfunction and Exercise Intolerance in Patients After Repair of Tetralogy of Fallot.</article-title>
            <source>J Am Heart Assoc</source>
            <year>2019</year>
            <month>Jan</month>
            <day>22</day>
            <volume>8</volume>
            <issue>2</issue>
            <fpage>e010903</fpage>
            <pub-id pub-id-type="pmid">30651018</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Havers-Borgersen</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Butt</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Smerup</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gislason</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>Torp-Pedersen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gr&#x000f6;ning</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>S&#x000f8;ndergaard</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>K&#x000f8;ber</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Fosb&#x000f8;l</surname>
                <given-names>EL</given-names>
              </name>
            </person-group>
            <article-title>Incidence of Infective Endocarditis Among Patients With Tetralogy of Fallot.</article-title>
            <source>J Am Heart Assoc</source>
            <year>2021</year>
            <month>Nov</month>
            <day>16</day>
            <volume>10</volume>
            <issue>22</issue>
            <fpage>e022445</fpage>
            <pub-id pub-id-type="pmid">34730003</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sun</surname>
                <given-names>HY</given-names>
              </name>
              <name>
                <surname>Proudfoot</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>McCandless</surname>
                <given-names>RT</given-names>
              </name>
            </person-group>
            <article-title>Prenatal detection of critical cardiac outflow tract anomalies remains suboptimal despite revised obstetrical imaging guidelines.</article-title>
            <source>Congenit Heart Dis</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>13</volume>
            <issue>5</issue>
            <fpage>748</fpage>
            <page-range>748-756</page-range>
            <pub-id pub-id-type="pmid">30022603</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mawad</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Mertens</surname>
                <given-names>LL</given-names>
              </name>
            </person-group>
            <article-title>Recent Advances and Trends in Pediatric Cardiac Imaging.</article-title>
            <source>Curr Treat Options Cardiovasc Med</source>
            <year>2018</year>
            <month>Feb</month>
            <day>21</day>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>9</fpage>
            <pub-id pub-id-type="pmid">29468314</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Refaat</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Ballout</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mansour</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Ablation of Atrial Fibrillation in Patients with Congenital Heart Disease.</article-title>
            <source>Arrhythm Electrophysiol Rev</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>6</volume>
            <issue>4</issue>
            <fpage>191</fpage>
            <page-range>191-194</page-range>
            <pub-id pub-id-type="pmid">29326834</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Al Habib</surname>
                <given-names>HF</given-names>
              </name>
              <name>
                <surname>Jacobs</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Mavroudis</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tchervenkov</surname>
                <given-names>CI</given-names>
              </name>
              <name>
                <surname>O'Brien</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Mohammadi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jacobs</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Contemporary patterns of management of tetralogy of Fallot: data from the Society of Thoracic Surgeons Database.</article-title>
            <source>Ann Thorac Surg</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>90</volume>
            <issue>3</issue>
            <fpage>813</fpage>
            <page-range>813-9; discussion 819-20</page-range>
            <pub-id pub-id-type="pmid">20732501</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sandoval</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Chaturvedi</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Benson</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Morgan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Van Arsdell</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Honjo</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Caldarone</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>KJ</given-names>
              </name>
            </person-group>
            <article-title>Right Ventricular Outflow Tract Stenting in Tetralogy of Fallot Infants With Risk Factors for Early Primary Repair.</article-title>
            <source>Circ Cardiovasc Interv</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>9</volume>
            <issue>12</issue>
            <pub-id pub-id-type="pmid">27965298</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Balzer</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary Valve Replacement for Tetralogy of Fallot.</article-title>
            <source>Methodist Debakey Cardiovasc J</source>
            <year>2019</year>
            <season>Apr-Jun</season>
            <volume>15</volume>
            <issue>2</issue>
            <fpage>122</fpage>
            <page-range>122-132</page-range>
            <pub-id pub-id-type="pmid">31384375</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bauser-Heaton</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Borquez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ladd</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Asija</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Downey</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Koth</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Algaze</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Wise-Faberowski</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Perry</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Shin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Peng</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Hanley</surname>
                <given-names>FL</given-names>
              </name>
              <name>
                <surname>McElhinney</surname>
                <given-names>DB</given-names>
              </name>
            </person-group>
            <article-title>Programmatic Approach to Management of Tetralogy of Fallot With Major Aortopulmonary Collateral Arteries: A 15-Year Experience With 458 Patients.</article-title>
            <source>Circ Cardiovasc Interv</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>10</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">28356265</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jonas</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Surgical Management of Absent Pulmonary Valve Syndrome.</article-title>
            <source>World J Pediatr Congenit Heart Surg</source>
            <year>2016</year>
            <month>Sep</month>
            <volume>7</volume>
            <issue>5</issue>
            <fpage>600</fpage>
            <page-range>600-4</page-range>
            <pub-id pub-id-type="pmid">27587495</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Valente</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Gauvreau</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Assenza</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Babu-Narayan</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Schreier</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gatzoulis</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Groenink</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Inuzuka</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kilner</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Koyak</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Landzberg</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Mulder</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Powell</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Wald</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Geva</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled in the INDICATOR cohort.</article-title>
            <source>Heart</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>100</volume>
            <issue>3</issue>
            <fpage>247</fpage>
            <page-range>247-53</page-range>
            <pub-id pub-id-type="pmid">24179163</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Geva</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Tetralogy of Fallot repair: ready for a new paradigm.</article-title>
            <source>J Thorac Cardiovasc Surg</source>
            <year>2012</year>
            <month>Jun</month>
            <volume>143</volume>
            <issue>6</issue>
            <fpage>1305</fpage>
            <page-range>1305-6</page-range>
            <pub-id pub-id-type="pmid">22342479</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yim</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Riesenkampff</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Caro-Dominguez</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Yoo</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Seed</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Grosse-Wortmann</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Assessment of Diffuse Ventricular Myocardial Fibrosis Using Native T1 in Children With Repaired Tetralogy of Fallot.</article-title>
            <source>Circ Cardiovasc Imaging</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>10</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">28292861</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tretter</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Redington</surname>
                <given-names>AN</given-names>
              </name>
            </person-group>
            <article-title>Risk Factors and Biomarkers of Poor Outcomes: Time to Throw Out Right Ventricular Volumes in Repaired Tetralogy of Fallot? Lessons From the INDICATOR Cohort.</article-title>
            <source>Circulation</source>
            <year>2018</year>
            <month>Nov</month>
            <day>06</day>
            <volume>138</volume>
            <issue>19</issue>
            <fpage>2116</fpage>
            <page-range>2116-2118</page-range>
            <pub-id pub-id-type="pmid">30474414</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Dusenbery</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Valente</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Powell</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Geva</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Myocardial ECV Fraction Assessed by CMR&#x000a0;Is Associated With Type of Hemodynamic Load and Arrhythmia in Repaired Tetralogy of Fallot.</article-title>
            <source>JACC Cardiovasc Imaging</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-10</page-range>
            <pub-id pub-id-type="pmid">26684969</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hui</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Slorach</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dragulescu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mertens</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bijnens</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Friedberg</surname>
                <given-names>MK</given-names>
              </name>
            </person-group>
            <article-title>Mechanisms of right ventricular electromechanical dyssynchrony and mechanical inefficiency in children after repair of tetralogy of fallot.</article-title>
            <source>Circ Cardiovasc Imaging</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>7</volume>
            <issue>4</issue>
            <fpage>610</fpage>
            <page-range>610-8</page-range>
            <pub-id pub-id-type="pmid">24785673</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Andrade</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Jerosch-Herold</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wegner</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gabbert</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Voges</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Pham</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hedderich</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kramer</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Rickers</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Determinants of Left Ventricular Dysfunction and Remodeling in Patients With Corrected Tetralogy of Fallot.</article-title>
            <source>J Am Heart Assoc</source>
            <year>2019</year>
            <month>Sep</month>
            <day>03</day>
            <volume>8</volume>
            <issue>17</issue>
            <fpage>e009618</fpage>
            <pub-id pub-id-type="pmid">31474177</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moon</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Choueiter</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Geva</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Valente</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Gauvreau</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Harrild</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Relation of biventricular strain and dyssynchrony in repaired tetralogy of fallot measured by cardiac magnetic resonance to death and sustained ventricular tachycardia.</article-title>
            <source>Am J Cardiol</source>
            <year>2015</year>
            <month>Mar</month>
            <day>01</day>
            <volume>115</volume>
            <issue>5</issue>
            <fpage>676</fpage>
            <page-range>676-80</page-range>
            <pub-id pub-id-type="pmid">25727084</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ghonim</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gatzoulis</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Ernst</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Moon</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Heng</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Keegan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>McCarthy</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Shore</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Uebing</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kempny</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Alpendurada</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Diller</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Dimopoulos</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Pennell</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Babu-Narayan</surname>
                <given-names>SV</given-names>
              </name>
            </person-group>
            <article-title>Predicting Survival in Repaired Tetralogy of Fallot: A Lesion-Specific and Personalized Approach.</article-title>
            <source>JACC Cardiovasc Imaging</source>
            <year>2022</year>
            <month>Feb</month>
            <volume>15</volume>
            <issue>2</issue>
            <fpage>257</fpage>
            <page-range>257-268</page-range>
            <pub-id pub-id-type="pmid">34656466</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Krieger</surname>
                <given-names>EV</given-names>
              </name>
              <name>
                <surname>Zeppenfeld</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>DeWitt</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Duarte</surname>
                <given-names>VE</given-names>
              </name>
              <name>
                <surname>Egbe</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Haeffele</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>KY</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Sillman</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Upadhyay</surname>
                <given-names>S</given-names>
              </name>
              <collab>American Heart Association Adults With Congenital Heart Disease Committee of the Council on Lifelong Congenital Heart Disease and Heart Health in the Young and Council on Clinical Cardiology</collab>
            </person-group>
            <article-title>Arrhythmias in Repaired Tetralogy of Fallot: A Scientific Statement From the American Heart Association.</article-title>
            <source>Circ Arrhythm Electrophysiol</source>
            <year>2022</year>
            <month>Nov</month>
            <volume>15</volume>
            <issue>11</issue>
            <fpage>e000084</fpage>
            <pub-id pub-id-type="pmid">36263773</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dennis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kotchetkova</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Pressley</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cordina</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Celermajer</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>Adults with repaired tetralogy: low mortality but high morbidity up to middle age.</article-title>
            <source>Open Heart</source>
            <year>2017</year>
            <volume>4</volume>
            <issue>1</issue>
            <fpage>e000564</fpage>
            <pub-id pub-id-type="pmid">28698799</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bokma</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Geva</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sleeper</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sompolinsky</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Babu-Narayan</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Wald</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Mulder</surname>
                <given-names>BJM</given-names>
              </name>
              <name>
                <surname>Valente</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Improved Outcomes After Pulmonary Valve&#x000a0;Replacement in Repaired Tetralogy&#x000a0;of Fallot.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2023</year>
            <month>May</month>
            <day>30</day>
            <volume>81</volume>
            <issue>21</issue>
            <fpage>2075</fpage>
            <page-range>2075-2085</page-range>
            <pub-id pub-id-type="pmid">37225360</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Giglia</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Massicotte</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Tweddell</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Barst</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Bauman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Erickson</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Feltes</surname>
                <given-names>TF</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hinoki</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ichord</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Kreutzer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>McCrindle</surname>
                <given-names>BW</given-names>
              </name>
              <name>
                <surname>Newburger</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Tabbutt</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Todd</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Webb</surname>
                <given-names>CL</given-names>
              </name>
              <collab>American Heart Association Congenital Heart Defects Committee of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Epidemiology and Prevention, and Stroke Council</collab>
            </person-group>
            <article-title>Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association.</article-title>
            <source>Circulation</source>
            <year>2013</year>
            <month>Dec</month>
            <day>17</day>
            <volume>128</volume>
            <issue>24</issue>
            <fpage>2622</fpage>
            <page-range>2622-703</page-range>
            <pub-id pub-id-type="pmid">24226806</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mouws</surname>
                <given-names>EMJP</given-names>
              </name>
              <name>
                <surname>de Groot</surname>
                <given-names>NMS</given-names>
              </name>
              <name>
                <surname>van de Woestijne</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>de Jong</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Helbing</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>van Beynum</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Bogers</surname>
                <given-names>AJJC</given-names>
              </name>
            </person-group>
            <article-title>Tetralogy of Fallot in the Current Era.</article-title>
            <source>Semin Thorac Cardiovasc Surg</source>
            <year>2019</year>
            <season>Autumn</season>
            <volume>31</volume>
            <issue>3</issue>
            <fpage>496</fpage>
            <page-range>496-504</page-range>
            <pub-id pub-id-type="pmid">30395964</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>He</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sznycer-Taub</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>McCarter</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jonas</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Hanumanthaiah</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Moak</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Magnesium Lowers the Incidence of Postoperative Junctional Ectopic Tachycardia in Congenital Heart Surgical Patients: Is There a Relationship to Surgical Procedure Complexity?</article-title>
            <source>Pediatr Cardiol</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>36</volume>
            <issue>6</issue>
            <fpage>1179</fpage>
            <page-range>1179-85</page-range>
            <pub-id pub-id-type="pmid">25762470</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sahu</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Siddharth</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Talwar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Abraham</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Choudhury</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Arrhythmias in Children in Early Postoperative Period After Cardiac Surgery.</article-title>
            <source>World J Pediatr Congenit Heart Surg</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>38</fpage>
            <page-range>38-46</page-range>
            <pub-id pub-id-type="pmid">29310559</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hoffman</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Bush</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Wernovsky</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Wieand</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Gaynor</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Spray</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Rhodes</surname>
                <given-names>LA</given-names>
              </name>
            </person-group>
            <article-title>Postoperative junctional ectopic tachycardia in children: incidence, risk factors, and treatment.</article-title>
            <source>Ann Thorac Surg</source>
            <year>2002</year>
            <month>Nov</month>
            <volume>74</volume>
            <issue>5</issue>
            <fpage>1607</fpage>
            <page-range>1607-11</page-range>
            <pub-id pub-id-type="pmid">12440616</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gatzoulis</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Till</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Redington</surname>
                <given-names>AN</given-names>
              </name>
            </person-group>
            <article-title>Depolarization-repolarization inhomogeneity after repair of tetralogy of Fallot. The substrate for malignant ventricular tachycardia?</article-title>
            <source>Circulation</source>
            <year>1997</year>
            <month>Jan</month>
            <day>21</day>
            <volume>95</volume>
            <issue>2</issue>
            <fpage>401</fpage>
            <page-range>401-4</page-range>
            <pub-id pub-id-type="pmid">9008456</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cuypers</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Menting</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Konings</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Opi&#x00107;</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Utens</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Helbing</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Witsenburg</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>van den Bosch</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Ouhlous</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>van Domburg</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Rizopoulos</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Meijboom</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Boersma</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bogers</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Roos-Hesselink</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Unnatural history of tetralogy of Fallot: prospective follow-up of 40 years after surgical correction.</article-title>
            <source>Circulation</source>
            <year>2014</year>
            <month>Nov</month>
            <day>25</day>
            <volume>130</volume>
            <issue>22</issue>
            <fpage>1944</fpage>
            <page-range>1944-53</page-range>
            <pub-id pub-id-type="pmid">25341442</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cabalka</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Asnes</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Balzer</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Cheatham</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Gillespie</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Justino</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Lung</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Turner</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>McElhinney</surname>
                <given-names>DB</given-names>
              </name>
            </person-group>
            <article-title>Transcatheter pulmonary valve replacement using the melody valve for treatment of dysfunctional surgical bioprostheses: A multicenter study.</article-title>
            <source>J Thorac Cardiovasc Surg</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>155</volume>
            <issue>4</issue>
            <fpage>1712</fpage>
            <page-range>1712-1724.e1</page-range>
            <pub-id pub-id-type="pmid">29395214</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Niwa</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Metabolic syndrome and coronary artery disease in adults with congenital heart disease.</article-title>
            <source>Cardiovasc Diagn Ther</source>
            <year>2021</year>
            <month>Apr</month>
            <volume>11</volume>
            <issue>2</issue>
            <fpage>563</fpage>
            <page-range>563-576</page-range>
            <pub-id pub-id-type="pmid">33968634</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marino</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Lipkin</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Newburger</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Peacock</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gerdes</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gaynor</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Mussatto</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Uzark</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Goldberg</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Bellinger</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Mahle</surname>
                <given-names>WT</given-names>
              </name>
              <collab>American Heart Association Congenital Heart Defects Committee, Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing, and Stroke Council</collab>
            </person-group>
            <article-title>Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association.</article-title>
            <source>Circulation</source>
            <year>2012</year>
            <month>Aug</month>
            <day>28</day>
            <volume>126</volume>
            <issue>9</issue>
            <fpage>1143</fpage>
            <page-range>1143-72</page-range>
            <pub-id pub-id-type="pmid">22851541</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Balci</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Drenthen</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Mulder</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Roos-Hesselink</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Voors</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Vliegen</surname>
                <given-names>HW</given-names>
              </name>
              <name>
                <surname>Moons</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sollie</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>van Dijk</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>van Veldhuisen</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Pieper</surname>
                <given-names>PG</given-names>
              </name>
            </person-group>
            <article-title>Pregnancy in women with corrected tetralogy of Fallot: occurrence and predictors of adverse events.</article-title>
            <source>Am Heart J</source>
            <year>2011</year>
            <month>Feb</month>
            <volume>161</volume>
            <issue>2</issue>
            <fpage>307</fpage>
            <page-range>307-13</page-range>
            <pub-id pub-id-type="pmid">21315213</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Xin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Pregnancy outcomes among 31 patients with tetralogy of Fallot, a retrospective study.</article-title>
            <source>BMC Pregnancy Childbirth</source>
            <year>2019</year>
            <month>Dec</month>
            <day>10</day>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>486</fpage>
            <pub-id pub-id-type="pmid">31823779</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Phillips</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pirics</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Congenital Heart Disease and Reproductive Risk: An Overview for Obstetricians, Cardiologists, and Primary Care Providers.</article-title>
            <source>Methodist Debakey Cardiovasc J</source>
            <year>2017</year>
            <season>Oct-Dec</season>
            <volume>13</volume>
            <issue>4</issue>
            <fpage>238</fpage>
            <page-range>238-242</page-range>
            <pub-id pub-id-type="pmid">29744016</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Townsley</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Windsor</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Briston</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Alegria</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ramakrishna</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Tetralogy of Fallot: Perioperative Management and Analysis of Outcomes.</article-title>
            <source>J Cardiothorac Vasc Anesth</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>33</volume>
            <issue>2</issue>
            <fpage>556</fpage>
            <page-range>556-565</page-range>
            <pub-id pub-id-type="pmid">29706570</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morray</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>McElhinney</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Boudjemline</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Gewillig</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Grant</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Bocks</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Armstrong</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Berman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Danon</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hoyer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Delaney</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Justino</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Qureshi</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Meadows</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>TK</given-names>
              </name>
            </person-group>
            <article-title>Multicenter Experience Evaluating Transcatheter Pulmonary Valve Replacement in Bovine Jugular Vein (Contegra) Right Ventricle to Pulmonary Artery Conduits.</article-title>
            <source>Circ Cardiovasc Interv</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>10</volume>
            <issue>6</issue>
            <pub-id pub-id-type="pmid">28600328</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Van Hare</surname>
                <given-names>GF</given-names>
              </name>
              <name>
                <surname>Ackerman</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Evangelista</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Kovacs</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Myerburg</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Shafer</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Warnes</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Washington</surname>
                <given-names>RL</given-names>
              </name>
              <collab>American Heart Association Electrocardiography and Arrhythmias Committee of Council on Clinical Cardiology, Council on Cardiovascular Disease in Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and American College of Cardiology</collab>
            </person-group>
            <article-title>Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 4: Congenital Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.</article-title>
            <source>Circulation</source>
            <year>2015</year>
            <month>Dec</month>
            <day>01</day>
            <volume>132</volume>
            <issue>22</issue>
            <fpage>e281</fpage>
            <page-range>e281-91</page-range>
            <pub-id pub-id-type="pmid">26621645</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Quattrone</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lie</surname>
                <given-names>OH</given-names>
              </name>
              <name>
                <surname>Nestaas</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>de Lange</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Try</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lindberg</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Skulstad</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Erikssen</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Edvardsen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Haugaa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Estensen</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Impact of pregnancy and risk factors for ventricular arrhythmias in women with tetralogy of Fallot.</article-title>
            <source>Open Heart</source>
            <year>2021</year>
            <month>Jan</month>
            <volume>8</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">33414183</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pedersen</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Pedersen</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Ravn</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Hjortdal</surname>
                <given-names>VE</given-names>
              </name>
            </person-group>
            <article-title>Outcomes of pregnancy in women with tetralogy of Fallot.</article-title>
            <source>Cardiol Young</source>
            <year>2008</year>
            <month>Aug</month>
            <volume>18</volume>
            <issue>4</issue>
            <fpage>423</fpage>
            <page-range>423-9</page-range>
            <pub-id pub-id-type="pmid">18559134</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Veldtman</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Connolly</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Grogan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ammash</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Warnes</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Outcomes of pregnancy in women with tetralogy of Fallot.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2004</year>
            <month>Jul</month>
            <day>07</day>
            <volume>44</volume>
            <issue>1</issue>
            <fpage>174</fpage>
            <page-range>174-80</page-range>
            <pub-id pub-id-type="pmid">15234429</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Diller</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Baumgartner</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Endocarditis in adults with congenital heart disease: new answers-new questions.</article-title>
            <source>Eur Heart J</source>
            <year>2017</year>
            <month>Jul</month>
            <day>07</day>
            <volume>38</volume>
            <issue>26</issue>
            <fpage>2057</fpage>
            <page-range>2057-2059</page-range>
            <pub-id pub-id-type="pmid">28329113</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30004.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Canobbio</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Warnes</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Aboulhosn</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Connolly</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Khanna</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Koos</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Mital</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rose</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Silversides</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Stout</surname>
                <given-names>K</given-names>
              </name>
              <collab>American Heart Association Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Functional Genomics and Translational Biology; and Council on Quality of Care and Outcomes Research</collab>
            </person-group>
            <article-title>Management of Pregnancy in Patients With Complex Congenital Heart Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association.</article-title>
            <source>Circulation</source>
            <year>2017</year>
            <month>Feb</month>
            <day>21</day>
            <volume>135</volume>
            <issue>8</issue>
            <fpage>e50</fpage>
            <page-range>e50-e87</page-range>
            <pub-id pub-id-type="pmid">28082385</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
